FDA NDC Directory · JSON-LD · Markdown

Olanzapine and Fluoxetine

NDC 0093-5503 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202074
Dosage form / routeCAPSULE · ORAL
Active ingredientsFLUOXETINE HYDROCHLORIDE (25 mg/1)
OLANZAPINE (3 mg/1)
Marketing started20130410
Package count1

External sources

Source: openFDA. Public-domain (CC0).